Jun. 26 at 3:57 PM
$SLS Gps Treatment ARM MOS is now > 31.5 Months
BAT / Aza+VEN
$ABBV $RHHBY Failed 3 AML Remission maintenance Trials.
VIALE-M CR1 Remission Maintenance Phase 3 Trial Failed
VIALE-T Post Transplant Maintenance Phase 3 Trial Failed
- Last week PH2/ low dose, all Oral combo - FAILED
This
$12 Stock is going to be a
$100 Stock and More.
Mark this Post.
Smart Money Knows.
$ABBV up
$25B in Market Value Last 2 Days...